EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer

Summary

Randomized, double-blind, placebo-controlled study for the treatment of head and neck cancer(HNC), to assess the ability of EN3285 to prevent or delay the onset of severe oral mucositis(OM).

Timeline

Start

2007-12

Primary completion

2009-06

Completion

2009-06

Outcome

Outcome not reported

Stopped: “Additional research”

Drugs

Indications